Mindray Medical, a Shenzhen medical device company, climbed 10% on Thursday following a report in Barron’s dealReporter that private equity companies approached the company with a privatization proposal. The report cited a unit of China’s CITIC bank as one of the interested firms. Mindray hasn’t commented, nor has the report been substantiated. Earlier this year, Mindray cut back its 2015 revenue growth forecast to 8.6% from 10%, blaming lower sales in China during the fourth quarter.
Help employers find you! Check out all the jobs and post your resume.
